From Feasibility study
AVL (BFS) VR8 (DFS) 1 Payback period 88 months 27 months 2 NPV(post-tax) 7.5% A$507M A$1.4B (US$896M) 3 Price V2O5/lb US$10.5 US$9.5 4 CAPEX A$604M (US$35M) A$329M (US$211M) 5 IRR(post-tax) 20.6% 42% 6 C3 Open v2O5/lb US$6.11 US$3.24 7 8 Market cap. $135.2M ~$50M
- Forums
- ASX - By Stock
- Ann: Annual Report to shareholders
AVL
australian vanadium limited
Add to My Watchlist
11.1%
!
0.8¢

From Feasibility study AVL (BFS)VR8 (DFS)Payback period 88...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.8¢ |
Change
-0.001(11.1%) |
Mkt cap ! $69.07M |
Open | High | Low | Value | Volume |
0.9¢ | 0.9¢ | 0.8¢ | $145.0K | 18.00M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 1354453 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 11191281 | 27 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 1354453 | 0.008 |
29 | 11332708 | 0.007 |
14 | 14868333 | 0.006 |
11 | 8033336 | 0.005 |
8 | 20780000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 11191281 | 27 |
0.010 | 19441622 | 40 |
0.011 | 5707537 | 21 |
0.012 | 6541796 | 18 |
0.013 | 3738838 | 18 |
Last trade - 16.21pm 27/06/2025 (20 minute delay) ? |
Featured News
AVL (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online